Drupal.behaviors.print = function(context) {window.print();window.close();}>
Med BioGene Amends Licensing Deal with Precision; Updates Litigation Status
October 03, 2012
Med BioGene Amends Licensing Deal with Precision; Updates Litigation Status
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
UPDATE: Signal Genetics Makes Improved Offer to Market Med BioGene Test
March 23, 2011 / GenomeWeb Daily News
Med BioGene Inks LungExpress Alliance with Precision Therapeutics
March 1, 2011 / GenomeWeb Daily News
Signal Genetics Adds Precision Therapeutics to Suit
February 25, 2011 / GenomeWeb Daily News
Med BioGene's 2012 Revenues Drop to Zero, as it Awaits Launch of NSCLC Test
April 9, 2013 / GenomeWeb Daily News
Med BioGene Shareholders Approve Commercialization Deal with Precision Therapeutics
April 13, 2011 / GenomeWeb Daily News